KPG-818

· Kangpu Biopharmaceuticals, Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KPG-818, covering 2024-05-23 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects [Phase 1]